However, the NAFLD + CIA/AAV-PTRF-KD group showed a marked reduction of α-SMA, PTRF, and their co-expression in hepatic stellate cells (HSCs) compared with those in the NAFLD + CIA/AAV-NC group. This evidence concerns the gene ACTA1 and metabolic dysfunction-associated steatotic liver disease.